Immunotherapy is a growing treatment area for cancer, with a lot of hype in the mainstream media. In this interview, recorded at the UK Oncology Nursing Society (UKONS) Annual Conference 2017, held in Harrogate, UK, Elaine Vickers, PhD, of Science Communicated Ltd, Manchester, UK, explains why this may not be a good thing, as many patients may get their hopes up when these treatments are only suitable for a small subset of cancer patients.
Curbing cancer patientsÂ’ expectations of immunotherapy
